• Explore /
  • Poster
  • / Comparison of efficacy and tolerance of first-line palliative chemotherapy EOX and mDCF regimens in patients with locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma without overexpression of HER2 receptors.

Comparison of efficacy and tolerance of first-line palliative chemotherapy EOX and mDCF regimens in patients with locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma without overexpression of HER2 receptors.

Abstract Poster

Authors

null

Sebastian Ochenduszko

Jagiellonian University Medical College, Cracow, Poland

Sebastian Ochenduszko , Kamil Konopka , Miroslawa Puskulluoglu , Katarzyna Urbanczyk , Andrzej Budzynski , Maciej Matlok , Agata Lazar , Anna Sinczak-Kuta , Krzysztof Krzemieniecki

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 135)

DOI

10.1200/jco.2015.33.3_suppl.135

Abstract #

135

Poster Bd #

C33

Abstract Disclosures

Similar Posters

First Author: Manish A. Shah

Poster

2018 Gastrointestinal Cancers Symposium

Patterns of chemotherapy (CT) use in a U.S.-wide cohort of patients (pts) with metastatic gastric cancer (MGC).

Patterns of chemotherapy (CT) use in a U.S.-wide cohort of patients (pts) with metastatic gastric cancer (MGC).

First Author: Thomas Adam Abrams

First Author: Claudia Pauligk

First Author: Lin Shen